Jade Biosciences (JBIO) Profit After Tax (2020 - 2026)
Jade Biosciences (JBIO) posted Profit After Tax of -$40.4 million for Q1 2026, down 26.93% on a QoQ basis from -$31.8 million in Q4 2025, and down 5.76% year-over-year from -$42.8 million in Q1 2025.
Jade Biosciences (JBIO) Profit After Tax (2020 - 2026) Analysis & Trends
Jade Biosciences' Profit After Tax history runs 7 years deep, the most recent figure standing at -$40.4 million for Q1 2026.
- Quarterly Profit After Tax fell 5.76% year-over-year to -$40.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$129.4 million (down 2.56% YoY) and the FY2025 annual result came in at -$127.3 million, down 82.46% from the prior year.
- Profit After Tax was -$40.4 million for Q1 2026 at Jade Biosciences, down from -$31.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$11.5 million in Q1 2022 and bottomed at -$47.0 million in Q4 2024.
- A 5-year average of -$23.9 million and a median of -$20.0 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 313.34% — and 2025, when it soared 32.3%.
- Jade Biosciences' Profit After Tax stood at -$14.7 million in 2022, then slumped by 35.58% to -$20.0 million in 2023, then tumbled by 135.45% to -$47.0 million in 2024, then surged by 32.3% to -$31.8 million in 2025, then slipped by 26.93% to -$40.4 million in 2026.
- Business Quant data shows JBIO's Profit After Tax at -$40.4 million in Q1 2026, -$31.8 million in Q4 2025, and -$25.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | -40.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.37 Mn |
| Dec 31, 2025 | -31.80 Mn |
| Sep 30, 2025 | -25.12 Mn |
| Jun 30, 2025 | -32.13 Mn |
| Mar 31, 2025 | -38.17 Mn |
| Dec 31, 2024 | -46.98 Mn |
| Sep 30, 2024 | -16.28 Mn |
| Jun 30, 2024 | -24.78 Mn |
| Mar 31, 2024 | -23.46 Mn |
| Dec 31, 2023 | -19.95 Mn |
| Sep 30, 2023 | -19.59 Mn |
| Jun 30, 2023 | -19.03 Mn |
| Mar 31, 2023 | -16.52 Mn |
| Dec 31, 2022 | -14.72 Mn |
| Sep 30, 2022 | -13.59 Mn |
| Jun 30, 2022 | -11.99 Mn |
| Mar 31, 2022 | -11.50 Mn |
| Dec 31, 2021 | -8.22 Mn |
| Sep 30, 2021 | -6.18 Mn |
| Jun 30, 2021 | -5.78 Mn |